display. Related News SEC News No records to display. Last Updated 30 December 2022 Last Reviewed 30 December 2022
List of Approved persons / Licensees Please wait... List of Approved persons / Licensees Name - Surname Mr. YASUAKI TANAKA Approval Type of approval Effective date Expiry date No records to display
strictly for reference. 2 Notification of the Office of Securities and Exchange Commission No. SorThor. 7/2557 Re: Rules on Appointing Independent Director of an Intermediary _____________________________ By
Notification of the Capital Market Supervisory Board Notification of the Office of Securities and Exchange Commission No. SorThor. 7/2557 Re: Rules on Appointing Independent Director of an
Notification of the Office of Securities and Exchange Commission No. SorThor. 7/2557 Re: Rules on Appointing Independent Director of an Intermediary _____________________________ By virtue of Clause
Office of the Securities and Exchange Commission No. SorThor. 50/2549 Re: Rules on Waiver for Appointment of Independent Director of Derivatives Broker _____________ By virtue of the second paragraph of
independent directors, and disclose complete information in their annual reports. Lately, most corporate governance assessments conducted by several foreign agencies were comparative studies with referable
around Baht 6.99 million in sales promotion expense, expense on hiring of OTC team, cost of exhibition booth display and sample products, etc. and an increase of about Baht 3.15 million in salary and car
compensation for distribution of the Company’s products through independent pharmacies, totaling approximately Baht 22.63 million which mounted year-on-year by Baht 19 .4 4 million ( the employment of Zuellig
products through independent pharmacies, totaling approximately Baht 22.63 million which mounted year-on-year by Baht 19 .4 4 million ( the employment of Zuellig Pharma Ltd. took effect as from September 1